Trial Profile
Phase III trial of a patented formulation of a Traditional Chinese Medicine in patients with coronary disorders
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 May 2013
Price :
$35
*
At a glance
- Drugs Cardiovascular therapies (Primary) ; Traditional Chinese medicine (Primary)
- Indications Coronary disorders
- Focus Registrational; Therapeutic Use
- 15 May 2013 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013, as reported in a China Pharma Holdings media release.
- 16 May 2012 New trial record